Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

作者:Voso M T*; Fianchi L; Criscuolo M; Greco M; D' Alo F; Hohaus S; Pagano L; Leone G
来源:Leukemia Research, 2012, 36(1): E15-E17.
DOI:10.1016/j.leukres.2011.08.010